Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Is There An Opportunity With Option Care Health, Inc.'s (NASDAQ:OPCH) 50% Undervaluation?

2024-09-04
Key Insights Option Care Health's estimated fair value is US$64.18 based on 2 Stage Free Cash Flow to Equity Option...

BrightSpring Health Services: Evaluating The Investment Case Seven Months Post-IPO

2024-08-29
BrightSpring Health Services stock has underperformed since its IPO. Check out why BTSG stock presents a mixed investment case.

From Nursing Dreams to a Life-Saving Team: A Journey of Overcoming Gastroparesis with Option Care Health

2024-08-26
By: Option Care Health August 26, 2024 In 2022, I graduated from nursing school with dreams of starting my career as a nurse. However, life had other plans. I was...

Option Care Health (NASDAQ:OPCH) shareholder returns have been splendid, earning 137% in 5 years

2024-08-17
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Option Care Health: Revenue Lines Not Pulling Economic Weight (Rating Downgrade)

2024-08-16
Option Care has numerous revenue lines that are not pulling their economic weight, acting as a drag on performance. Learn why OPCH stock is a Hold.

Option Care Health Breaks Above 200-Day Moving Average - Bullish for OPCH

2024-08-13
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?

2024-08-05
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Should Value Investors Buy Option Care Health (OPCH) Stock?

2024-08-01
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Option Care Health Second Quarter 2024 Earnings: Beats Expectations

2024-08-01
Option Care Health ( NASDAQ:OPCH ) Second Quarter 2024 Results Key Financial Results Revenue: US$1.23b (up 15% from 2Q...

Should You Believe in the Growth Potential of Option Care Health (OPCH)?

2024-08-01
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, the fund delivered -8.55% gross and -8.67% net of fees compared to a -2.92% return for the Russell 2000 Growth Index and a -1.41% return […]